healthy
Showing NaN - NaN of 252
Healthy Trial in Seoul (Physical activity)
Completed
- Healthy
- Physical activity
-
Seoul, Korea, Republic ofSeoul National University
Jun 22, 2023
Healthy Trial in Seoul (Remimazolam, Midazolam)
Not yet recruiting
- Healthy
-
Seoul, Korea, Republic ofSamsung Medical Center
Apr 19, 2023
Healthy Trial in Seoul (JP-1366 20mg tablet, JP-1366 20mg capsule)
Completed
- Healthy
- JP-1366 20mg tablet
- JP-1366 20mg capsule
-
Seoul, Korea, Republic ofYangji Hospital
Apr 17, 2023
Healthy Trial in Seoul (Test Drug(JW0302) or Reference Drug(C2206))
Not yet recruiting
- Healthy
- Test Drug(JW0302) or Reference Drug(C2206)
-
Seoul, Korea, Republic ofClinical Trial Center, Seoul National University Hospital
Mar 14, 2023
Healthy Trial in Seoul (JP-1366 20mg tablet)
Not yet recruiting
- Healthy
- JP-1366 20mg tablet
-
Seoul, Korea, Republic ofAsan Medical Central
Jan 25, 2023
Healthy Trial in Seoul (C1K 150mg, C1K 300mg, Placebo with the same volume of C1K 300mg)
Recruiting
- Healthy
- C1K 150mg
- +8 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 25, 2023
Healthy Trial in Seoul (ID120040002, Compound-X, Placebo comparator)
Recruiting
- Healthy
- ID120040002
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Dec 21, 2022
Healthy Trial (Sildenafil, Erythromycin, Itraconazole)
Completed
- Healthy
- Sildenafil
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 25, 2022
Healthy Trial in Seoul (HGP1910, HGP1909, HCP1903)
Completed
- Healthy
- HGP1910
- +2 more
-
Seoul, Korea, Republic ofKorea University Anam Hospital
Jul 12, 2022
Healthy Trial in Seoul (DA-5218, DA-5218-R1 + DA-5218-R2 + DA-5218-R3)
Not yet recruiting
- Healthy
- DA-5218
- DA-5218-R1 + DA-5218-R2 + DA-5218-R3
-
Seoul, Korea, Republic ofBumin Hospital
Jul 4, 2022
Healthy Trial in Seoul (Reference Drug or Test Drug)
Recruiting
- Healthy
- Reference Drug or Test Drug
-
Seoul, Korea, Republic ofClinical Trial Center, Seoul National University Hospital
Jun 22, 2022
Healthy Trial in Seoul (DA-5211, DA-5211-R1 + DA-5211-R2)
Completed
- Healthy
- DA-5211
- DA-5211-R1 + DA-5211-R2
-
Seoul, Korea, Republic ofBumin Hospital
Jun 2, 2022
Healthy Trial in Seoul (DA-5210 10/1000mg, DA-5210-R 10/1000mg)
Completed
- Healthy
- DA-5210 10/1000mg
- DA-5210-R 10/1000mg
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Jun 2, 2022
Healthy Trial in Seoul (DA-5210 10/500mg, DA-5210-R 10/500mg)
Completed
- Healthy
- DA-5210 10/500mg
- DA-5210-R 10/500mg
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Jun 2, 2022
Healthy Trial in Seoul (DA-5210 10/500mg, DA-5210-R 10/500mg)
Completed
- Healthy
- DA-5210 10/500mg
- DA-5210-R 10/500mg
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Jun 2, 2022
Healthy Trial in Seoul (DA-5210 10/1000mg, DA-5210-R 10/1000mg)
Completed
- Healthy
- DA-5210 10/1000mg
- DA-5210-R 10/1000mg
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Jun 2, 2022
Healthy Trial in Seoul (Polmacoxib, Pregabalin)
Completed
- Healthy
-
Seoul, Korea, Republic ofSeoul National University Hospital
May 26, 2022
Healthy Trial in Seoul (Polmacoxib and Tramadol combination, Polmacoxib, Tramadol HCl)
Completed
- Healthy
- Polmacoxib and Tramadol combination
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
May 24, 2022